Saving lives by making malaria drugs more affordable

6 abril 2015

The ‘shelf life’ of malaria-fighting drugs plays a significant role in how donors should subsidize the medicine in order to ensure better affordability for patients, a new report suggests. Forty percent of all malaria-caused deaths in sub-Saharan Africa occur in the Democratic Republic of Congo and Nigeria, according to the World Health Organization. The private sector «supply chain» manages 74% of the drug volume in Congo and 98% in Nigeria where malaria-stricken patients rely on «drug shops» and other for-profit retail outlets to get life-saving medicine.